$WD

Walker & Dunlop, Inc. (WD): Results of Operations and Financial Condition

Walker & Dunlop, Inc. (WD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 wd-20260806xex99d1.htm EX-99.1 Exhibit 99.1 Walker & Dunlop Reports Second Quarter 2026 Financial Results ​ BETHESDA, MD – AUGUST 6, 2026 – Walker & Dunlop, Inc. (NYSE: WD) (the “Company”, “Walker & Dunlop” or “W&D”) reported second quarter 2026 financial results. ​ KEY

Original reporting
Published Aug 6, 2026, 10:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 10:35 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$WD
Bearish
medium confidence
Mentioned
$WD
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$WDBearishMed
01

Why it matters

The filing discloses Q2 2026 financial results and key operating metrics, including transaction volume, revenue, net income, adjusted core EPS, servicing portfolio size, and legacy repurchase-related charges and reserves.

02

Market read

Traders can reassess WD’s earnings power and credit risk trajectory using the disclosed legacy charge magnitude, repurchased-loan exposure reduction, and servicing portfolio growth.

03

What to watch

Investors may underweight the mix shift toward brokered transactions (MSR income down) and the stated reduction in repurchased-loan exposure ($39.4M since quarter end) when assessing forward earnings risk.

Relevance 7/10Novelty 7/10Timing: filed pre-market today (Aug 6, 2026) with Q2 2026 financial results

Background

This is an SEC Form 8-K (Item 2.02) filing attaching Walker & Dunlop’s Q2 2026 earnings release (Exhibit 99.1).

Company-level read

Ticker impact

$WDBearishMedium confidence
Context

Walker & Dunlop reported Q2 2026 results, including revenues down 4% and net income down 91%, plus $23.2M of legacy repurchase and credit-related charges.

Expected impact

Near-term sentiment likely pressured by the large year-over-year net income decline, while investors may focus on stabilization as legacy reviews near conclusion.

Evidence & confidence

The filing provides concrete P&L and portfolio metrics for Q2 2026, with management attributing weakness to legacy repurchases/credit marks and highlighting ongoing market share gains and servicing growth.

Market effects

Commercial real estate capital markets and agency lending sentiment may be influenced by evidence of continued transaction activity and servicing growth despite earnings volatility from legacy credit marks.

Primarily US-focused agency multifamily lending and servicing activity.

Limited direct global impact; effects are concentrated in US agency and CRE financing markets.

Counterpoint

The headline net income decline is largely tied to legacy repurchase and credit marks, while adjusted core EPS rose 3% and servicing portfolio grew 6%, suggesting underlying operating resilience.

Key entities

  • Walker & Dunlop, Inc.

    Reported Q2 2026 financial results and provided detail on legacy repurchase/credit marks, transaction volume, and servicing portfolio growth.

  • Fannie Mae and Freddie Mac

    Management references GSE lending capacity and Walker & Dunlop’s market share with the agencies.

Related articles

$WDMedAI 8/10

Why Walker & Dunlop (WD) Stock Is Trading Up Today

Walker & Dunlop (NYSE:WD) shares rose 5.6% after the company said it arranged more than $223 million in bridge financing for five multifamily communities on behalf of Madison Capital Group. The financing covers 1,345 units across North Carolina, South Carolina, and Florida. The article notes WD has had limited >5% moves over the past year.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.

$CPTMedAI 8/10

Camden Property Trust (CPT) Q2 2026 Earnings Call Transcript

Camden Property Trust (CPT) discussed its Q2 2026 earnings call, focusing on exiting its California multifamily portfolio. According to management, it sold the 19-year-old California portfolio for $1.625 billion, with trailing 12-month FFO and AFFO yields of 5.6% and 5.2%. Camden repurchased $694 million of shares and closed $645 million of acquisitions plus $195 million of awarded acquisitions, reaffirming $6.75/share FFO guidance.